Global infectious disease research collaborations in crises: building capacity and inclusivity through cooperation

Background The initial research requirements in pandemics are predictable. But how is it possible to study a disease that is so quickly spreading and to rapidly use that research to inform control and treatment? Main body In our view, a dilemma with such wide-reaching impact mandates multi-disciplinary collaborations on a global scale. International research collaboration is the only means to rapidly address these fundamental questions and potentially change the paradigm of data sharing for the benefit of patients throughout the world. International research collaboration presents significant benefits but also barriers that need to be surmounted, especially in low- and middle-income countries. Conclusion Facilitating international cooperation, by building capacity in established collaborative platforms and in low- and middle-income countries, is imperative to efficiently answering the priority clinical research questions that can change the trajectory of a pandemic.

Automated summary

International research collaboration is essential for addressing rapidly spreading diseases, but barriers exist, especially in low- and middle-income countries. Building capacity and collaborative platforms in these countries is crucial for efficiently answering clinical research questions and changing the trajectory of a pandemic.